![Stefan Sperl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Sperl
Chief Operating Officer at
KIORA PHARMACEUTICALS, INC.
Profile
Stefan Sperl was the founder of Panoptes Pharma GmbH, founded in 2013, holding the title of Chief Operating Officer.
Dr. Sperl is currently the Executive Vice President-CMC & Operations at Kiora Pharmaceuticals, Inc. Formerly, Project Manager at Nabriva Therapeutics GmbH.
Education includes a doctorate from Max Planck Institute of Biochemistry.
Stefan Sperl active positions
| Companies | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Chief Operating Officer | - |
Former positions of Stefan Sperl
| Companies | Position | End |
|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Corporate Officer/Principal | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Founder | - |
Training of Stefan Sperl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Health Technology |
- Stock Market
- Insiders
- Stefan Sperl
